CH311612A - Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). - Google Patents
Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).Info
- Publication number
- CH311612A CH311612A CH311612DA CH311612A CH 311612 A CH311612 A CH 311612A CH 311612D A CH311612D A CH 311612DA CH 311612 A CH311612 A CH 311612A
- Authority
- CH
- Switzerland
- Prior art keywords
- anilide
- methyl
- cyclohexylamine
- chloro
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
Description
Verfahren zur Herstellung eines neuen basisch substituierten FettsÏure (2-halogen-6-methyl-anilids).
Gegenstand des vorliegenden Patentes bilclet ein Verfahren zur Herstellung eines neuen basisch substituierten Fet$säure- (Whalegen-6- methyl-anilids), welches dadurch gekennzeich- net ist, dass man eine Verbindung der Formel
EMI1.1
in welcher X einen reaktionsfähigen, während der Reaktion sich abspaltenden Rest bedeutet, mit Cyclohexylamin umsetzt.
Der Rest X kann in einem Halogenatom oder einem sonstigen für den Austa. usch gegen den basisehen Rest geeigneten reaktionsfähigen Substituenten, wie z. B. einer Alkylsulfonyloxy- oder Arylsulfonyloxygruppe, bestehen. Der Austauseh der Gruppe X gegen den Cyclohexylaminrest erfolgt z. B. durch einfaches Erwärmen mit Cyclohexylamin gege benenfalls in Gegenwart eines basisch reagie renden Kondensationsmittels oder von Cyclohexylamin im Überschuss. Das Cyclohexyl amino-acet- (2-chlor-6-methyl-anilid) ist ein farbloses 61. Das Hydrochlorid der Base schmilzt bei 231-233 .
Das neue Anilid soll als Lokalanästhetikum und als Zwischenprodukt zur Herstellung weiterer Derivate Verwendung finden.
Beispiel:
36 Gewichtsteile Chloracet- (2-chlor-6-me- th, vl-anilid) (gewonnen dureh ITmsetzen von 2-Chlor-6-methyl-anilin mit Chloracetylchlorid in Gegenwart von Natriumacetat, Schmp. 140 bis 141 ) werden in 80 Gewichtsteilen Äthanol suspendiert und mit 50 Gewichtsteilen Cyclohexylamin verset. zt. Die Temperatur steigt dabei leicht an und ein grosser Teil des Reak- tionsgemisehes geht in Losung. Nun wird wÏhrend 4 Stunden bei Zimmertemperatur ge riihrt und dann einige Stunden bei Siedetemperatur.
Mit Wasserdampf wird hierauf der Alkohol und das überschüssige Cyclohexyl- a. min abgeblasen und naeh dem Erkalten das zurückbleibende Öl in Äther aufgenommen.
Nach dem Trocknen der ätherisehen Lösung und Verjagen des Losungsmittels verbleibt ein Öl, das durch Überführen in das Hydrochlorid gereinigt wird. Man erhält 30 Ge wichtsteile reines Cyclohexylamino-acet- (2 chlor-6-methyl-anilid). Die Umsetzung mit Cyelohexylamin kann auch in Benzol stattfinden.
PATENTANSPRUCH :
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure- (2-halogen-6- methyl-anilids), dadurch gekennzeiehnet, dass man eine Verbindung der Formel
EMI1.2
in welcher X einen reaktionsfähigen, während der Reaktion sich abspaltenden Rest bedeutet,
**WARNUNG** Ende DESC Feld konnte Anfang CLMS uberlappen**.
Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
The subject of the present patent is a process for the production of a new basic substituted fatty acid (Whalegen-6-methyl-anilide) which is characterized in that a compound of the formula
EMI1.1
in which X is a reactive radical which is split off during the reaction, reacts with cyclohexylamine.
The radical X can be in a halogen atom or another for the Austa. usch against the basic radical suitable reactive substituents, such as. B. an alkylsulfonyloxy or arylsulfonyloxy group exist. The exchange of group X against the cyclohexylamine radical takes place z. B. by simply heating with cyclohexylamine, if necessary, in the presence of a basic reacting condensing agent or of cyclohexylamine in excess. The cyclohexylamino-acet- (2-chloro-6-methyl-anilide) is a colorless 61. The hydrochloride of the base melts at 231-233.
The new anilide is to be used as a local anesthetic and as an intermediate product for the production of further derivatives.
Example:
36 parts by weight of chloroacet- (2-chloro-6-meth, vl-anilide) (obtained by reacting 2-chloro-6-methyl-aniline with chloroacetyl chloride in the presence of sodium acetate, melting point 140 to 141) are added in 80 parts by weight Suspended ethanol and mixed with 50 parts by weight of cyclohexylamine. nt. The temperature rises slightly and a large part of the reaction mixture goes into solution. The mixture is then stirred for 4 hours at room temperature and then for a few hours at boiling temperature.
The alcohol and the excess cyclohexyl-a are then removed with steam. min blown off and after cooling the remaining oil absorbed in ether.
After the ethereal solution has dried and the solvent has been driven off, an oil remains which is purified by converting it into the hydrochloride. 30 parts by weight of pure cyclohexylamino-acet- (2 chloro-6-methyl-anilide) are obtained. The reaction with cyelohexylamine can also take place in benzene.
PATENT CLAIM:
Process for the preparation of a new basic substituted fatty acid (2-halogen-6-methyl-anilide), characterized in that a compound of the formula
EMI1.2
in which X is a reactive radical that is split off during the reaction,
** WARNING ** End of DESC field could overlap beginning of CLMS **.
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH311612T | 1952-02-25 | ||
CH307799T | 1952-11-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH311612A true CH311612A (en) | 1955-11-30 |
Family
ID=25735345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH311612D CH311612A (en) | 1952-02-25 | 1952-02-25 | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). |
Country Status (1)
Country | Link |
---|---|
CH (1) | CH311612A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10780083B1 (en) | 2019-03-11 | 2020-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10786485B1 (en) | 2019-03-11 | 2020-09-29 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10842798B1 (en) | 2019-11-06 | 2020-11-24 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10927096B2 (en) | 2019-03-11 | 2021-02-23 | Nocion Therapeutics, Inc. | Ester substituted ion channel blockers and methods for use |
US10934263B2 (en) | 2019-03-11 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10933055B1 (en) | 2019-11-06 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10968179B2 (en) | 2019-03-11 | 2021-04-06 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11332446B2 (en) | 2020-03-11 | 2022-05-17 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
-
1952
- 1952-02-25 CH CH311612D patent/CH311612A/en unknown
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11512058B2 (en) | 2019-03-11 | 2022-11-29 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10786485B1 (en) | 2019-03-11 | 2020-09-29 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10828287B2 (en) | 2019-03-11 | 2020-11-10 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10780083B1 (en) | 2019-03-11 | 2020-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10927096B2 (en) | 2019-03-11 | 2021-02-23 | Nocion Therapeutics, Inc. | Ester substituted ion channel blockers and methods for use |
US10934263B2 (en) | 2019-03-11 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11643404B2 (en) | 2019-03-11 | 2023-05-09 | Nocion Therapeutics, Inc. | Ester substituted ion channel blockers and methods for use |
US10968179B2 (en) | 2019-03-11 | 2021-04-06 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11603355B2 (en) | 2019-03-11 | 2023-03-14 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11377422B2 (en) | 2019-03-11 | 2022-07-05 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10842798B1 (en) | 2019-11-06 | 2020-11-24 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10933055B1 (en) | 2019-11-06 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11696912B2 (en) | 2019-11-06 | 2023-07-11 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11332446B2 (en) | 2020-03-11 | 2022-05-17 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH421078A (en) | Process for the preparation of aminoacetylene compounds | |
CH311612A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311613A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311606A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311610A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311614A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311608A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311609A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311607A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311615A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311611A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311644A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311632A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311642A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311631A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311629A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311605A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311603A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311624A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311604A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311639A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH312572A (en) | Process for the preparation of a new basic substituted fatty acid (2-halo-6-methyl) anilide | |
CH311630A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311619A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). | |
CH311633A (en) | Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). |